Patents Assigned to APRINOIA THERAPEUTICS INC.
  • Heteroaryl compounds and uses thereof
    Patent number: 12116364
    Abstract: Described herein are compounds of formula (I), and pharmaceutically acceptable salts, solvates, hydrates, isotopically labeled derivatives and radiolabeled derivative thereof, and pharmaceutical compositions thereof. Also provided are methods and kits involving the inventive compounds or compositions for detecting and imaging Tau aggregates in the brain for detection of Alzheimer's disease (AD) in a subject.
    Type: Grant
    Filed: May 9, 2019
    Date of Patent: October 15, 2024
    Assignee: APRINOIA THERAPEUTICS INC.
    Inventors: Ming-Kuei Jang, Paul Tempest
  • HETEROARYL COMPOUNDS AND USES THEREOF
    Publication number: 20230047178
    Abstract: Described herein are compounds of formula (I), and pharmaceutically acceptable salts, solvates, hydrates, isotopically labeled derivatives and radiolabeled derivative thereof, and pharmaceutical compositions thereof. Also provided are methods and kits involving the inventive compounds or compositions for detecting and imaging Tau aggregates in the brain for detection of Alzheimer's disease (AD) in a subject.
    Type: Application
    Filed: September 16, 2021
    Publication date: February 16, 2023
    Applicant: APRINOIA THERAPEUTICS INC.
    Inventors: Ming-Kuei JANG, Paul TEMPEST
  • HETEROARYL COMPOUNDS AND USES THEREOF
    Publication number: 20210253569
    Abstract: Described herein are compounds of formula (I), and pharmaceutically acceptable salts, solvates, hydrates, isotopically labeled derivatives and radiolabeled derivative thereof, and pharmaceutical compositions thereof. Also provided are methods and kits involving the inventive compounds or compositions for detecting and imaging Tau aggregates in the brain for detection of Alzheimer's disease (AD) in a subject.
    Type: Application
    Filed: May 9, 2019
    Publication date: August 19, 2021
    Applicant: APRINOIA THERAPEUTICS INC.
    Inventors: Ming-Kuei JANG, Paul TEMPEST
  • ANTIBODIES THAT BIND TO PATHOLOGICAL TAU SPECIES AND USES THEREOF
    Publication number: 20210163582
    Abstract: The present disclosure relates to antibodies that bind selectively to pathological Tau, including compositions and methods relating to such antibodies, such as for treating tauopathies, neurodegenerative diseases associated with pathological aggregation of Tau.
    Type: Application
    Filed: February 8, 2021
    Publication date: June 3, 2021
    Applicant: APRINOIA THERAPEUTICS INC.
    Inventors: Ming-Kuei JANG, Chin-Yin TAI